One possible explanation for the discrepancy between increased basal ex vivo IL-6 secretion but unaffected basal plasma IL-6 levels could be that COVID-19 vaccines only “prime” systemic PBMCs and that a second hit, as for instance the isolation process or ex vivo culturing, is required to fully activate these cells. The gene discussed is IL6; the disease is COVID-19.